PlainRecalls
FDA Drug Low Class III Ongoing

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

Reported: March 13, 2024 Initiated: February 20, 2024 #D-0364-2024

Product Description

Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

Reason for Recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Details

Units Affected
45,875 bottles
Distribution
Nationwide in the U.S. and Puerto Rico
Location
Mississauga

Frequently Asked Questions

What product was recalled?
Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61. Recalled by Contract Pharmaceuticals Limited Canada. Units affected: 45,875 bottles.
Why was this product recalled?
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2024. Severity: Low. Recall number: D-0364-2024.